Clinical Research Activities
Craving and Medications:
Optimizing Treatment Response
This study will examine the degree to which a subset of alcohol dependent individuals who exhibit high craving respond to treatment with naltrexone. Moreover, we will examine the degree to which genotype and comorbid conditions such as depression impact craving and treatment outcomes. Alcohol dependent subjects from the Hazelden residential program at Center City who have been offered naltrexone as part of their treatment plan will be recruited. Patients will complete daily assessments of craving during their treatment stay as well as follow up assessments at 1, 6, and 12 months after discharge.
